The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 6789 -6798
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0801525

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Boehmler, A. M.
Right arrow Articles by Möhle, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boehmler, A. M.
Right arrow Articles by Möhle, R.

The CysLT1 Ligand Leukotriene D4 Supports {alpha}4β1- and {alpha}5β1-Mediated Adhesion and Proliferation of CD34+ Hematopoietic Progenitor Cells1

Andreas M. Boehmler*, Adriana Drost*, Lena Jaggy*, Gabriele Seitz*, Tina Wiesner*, Claudio Denzlinger{dagger}, Lothar Kanz* and Robert Möhle2,*

* Department of Medicine II, University of Tübingen, Tübingen, Germany; and {dagger} Department of Medicine III, Marienhospital, Stuttgart, Germany

Cytokines and chemokines control hematopoietic stem and progenitor cell (HPC) proliferation and trafficking. However, the role of nonpeptide mediators in the bone marrow microenvironment has remained elusive. Particularly CysLT1, a G protein-coupled receptor recognizing inflammatory mediators of the cysteinyl leukotriene family, is highly expressed in HPCs. We therefore analyzed the effects of its ligands on human CD34+ HPCs. The most potent CysLT1 ligand, LTD4, rapidly and significantly up-regulated {alpha}4β1 and {alpha}5β1 integrin-dependent adhesion of both primitive and committed HPC. LTD4-triggered adhesion was inhibited by specific CysLT1 antagonists. The effects of other CysLT1 ligands were weak (LTC4) or absent (LTE4). In serum-free liquid cultures supplemented with various hematopoietic cytokines including IL-3, only LTD4 significantly augmented the expansion of HPCs in a dose-dependent manner comparable to that of peptide growth factors. LTC4 and LTE4 were less effective. In CD34+ cell lines and primary HPCs, LTD4 induced phosphorylation of p44/42 ERK/MAPK and focal adhesion kinase-related tyrosine kinase Pyk2, which is linked to integrin activation. Bone marrow stromal cells produced biologically significant amounts of cysteinyl leukotrienes only when hematopoietic cells were absent, suggesting a regulatory feedback mechanism in the hematopoietic microenvironment. In contrast to antagonists of the homing-related G protein-coupled receptor CXCR4, administration of a CysLT1 antagonist failed to induce human CD34+ HPC mobilization in vivo. Our results suggest that cysteinyl leukotriene may contribute to HPC retention and proliferation only when cysteinyl leukotriene levels are increased either systemically during inflammation or locally during marrow aplasia.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 510/A4 and Deutsche José Carreras Leukämiestiftung Grants DJCLS R04/13 and R08/24v.

2 Address correspondence and reprint requests to Dr. Robert Möhle, Department of Medicine II, University of Tübingen, Otfried-Müller-Strasse 10, 72076 Tübingen, Germany. E-mail address: robert.moehle{at}med.uni-tuebingen.de

3 Abbreviations used in this paper: HPC, hematopoietic stem and progenitor cell; BMEC, bone marrow endothelial cell; CAFC, cobblestone area-forming cell; EIA, enzyme immunoassay; GPCR, G protein-coupled receptor; 5-LO, 5-lipoxygenase; LT, leukotriene; MPA, mycophenolic acid; PTX, pertussis toxin; rh, recombinant human; SDF, stromal cell-derived factor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.